Human Milk Oligosaccharides (HMOs) are complex carbohydrates naturally found in breast milk that function as prebiotics, selectively nourishing beneficial gut bacteria rather than being digested directly. The most widely studied forms, 2'-fucosyllactose (2'-FL) and lacto-N-neotetraose (LNnT), are now produced through biofermentation and available as supplements. Research suggests that HMOs support gut health by promoting the growth of beneficial Bifidobacteria, strengthening the intestinal barrier, and modulating immune responses. Studies indicate that supplementation with 2'-FL and LNnT in adults may help alleviate symptoms associated with irritable bowel syndrome, including bloating and abdominal discomfort. Additionally, emerging evidence points to antimicrobial properties, as HMOs may inhibit the adhesion of certain pathogens to gut cells, offering a protective mechanism that extends well beyond infancy.
Compare this supplementResearch suggests that human milk oligosaccharides (HMOs) possess meaningful antimicrobial properties, with studies d...
View studies →Research suggests that human milk oligosaccharides play a meaningful role in shaping early gut microbiome development...
View studies →The available studies submitted for this topic do not contain research on Human Milk Oligosaccharides or IBS. The sin...
View studies →Research suggests that human milk oligosaccharides support immune and gut health primarily by selectively feeding ben...
View studies →These are commonly referenced dosage ranges for this supplement. They are not medical recommendations. Always consult a healthcare provider before supplementing.
| Form | Dose range | Frequency | Studied for | Source |
|---|---|---|---|---|
| Liquid | 1–2 g | Daily | infant gut health and antimicrobial defense | Naturally present in human breast milk; supplemental doses studied in infant formula research |
| Powder | 5 g | Daily | general gut health and bifidobacterium enrichment | Standard dose used in multiple human intervention trials with 2'FL |
| Powder | 5–10 g | Daily | gut health and microbiome modulation | Common in clinical trials examining prebiotic effects on adult gut microbiota |
| Powder | 2–5 g | Daily | IBS relief and GI symptom reduction | Used in RCTs investigating IBS symptoms; 2'FL and LNnT combinations studied |
| Powder | 10–20 g | Daily | immune function support in adults | Higher doses studied in trials assessing immune modulation and systemic inflammation |